These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3060442)
1. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation. Morecki S; Slavin S Isr J Med Sci; 1988; 24(9-10):488-93. PubMed ID: 3060442 [TBL] [Abstract][Full Text] [Related]
2. Purging breast cancer cells in preparation for autologous bone marrow transplantation. Morecki S; Pavlotzky F; Margel S; Slavin S Bone Marrow Transplant; 1987 Apr; 1(4):357-63. PubMed ID: 3332143 [TBL] [Abstract][Full Text] [Related]
3. Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow. Morecki S; Margel S; Slavin S Cancer Res; 1988 Aug; 48(16):4573-7. PubMed ID: 3396008 [TBL] [Abstract][Full Text] [Related]
4. Differential binding of soybean agglutinin to human neuroblastoma cell lines: potential application to autologous bone marrow transplantation. Reisner Y; Gan J Cancer Res; 1985 Sep; 45(9):4026-31. PubMed ID: 2411394 [TBL] [Abstract][Full Text] [Related]
5. Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purging. Mumcuoglu M; Favrot M; Slavin S Exp Hematol; 1990 Jan; 18(1):55-60. PubMed ID: 2298270 [TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of combination drug purging for autologous bone marrow transplantation. Jones RJ; Miller CB; Zehnbauer BA; Rowley SD; Colvin OM; Sensenbrenner LL Bone Marrow Transplant; 1990 May; 5(5):301-7. PubMed ID: 2350626 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide. Passos-Coelho J; Ross AA; Davis JM; Huelskamp AM; Clarke B; Noga SJ; Davidson NE; Kennedy MJ Cancer Res; 1994 May; 54(9):2366-71. PubMed ID: 8162582 [TBL] [Abstract][Full Text] [Related]
8. Elimination of malignant clonogenic breast cancer cells from human bone marrow. Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144 [TBL] [Abstract][Full Text] [Related]
9. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems. Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119 [TBL] [Abstract][Full Text] [Related]
10. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads. Elias AD; Pap SA; Bernal SD Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434 [TBL] [Abstract][Full Text] [Related]
11. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Shpall EJ; Bast RC; Joines WT; Jones RB; Anderson I; Johnston C; Eggleston S; Tepperberg M; Edwards S; Peters WP Bone Marrow Transplant; 1991 Feb; 7(2):145-51. PubMed ID: 2049558 [TBL] [Abstract][Full Text] [Related]
12. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow. Tamayo E; Hervé P Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544 [TBL] [Abstract][Full Text] [Related]
13. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989 [No Abstract] [Full Text] [Related]
14. An effective immunomagnetic method for bone marrow purging in T cell malignancies. Wang MY; Kvalheim G; Kvaløy S; Beiske K; Jakobsen E; Wijdenes J; Pihl A; Fodstad O Bone Marrow Transplant; 1992 May; 9(5):319-23. PubMed ID: 1617315 [TBL] [Abstract][Full Text] [Related]
15. Limiting dilution analysis for detection of residual leukemic cells after bone marrow combined decontamination with mafosfamide followed by merocyanine-540-mediated photosensitization. Porcellini A; Rossi MT; Manna A; Sparaventi G; Pazzaglia C Int J Cell Cloning; 1989 Jul; 7(4):223-31. PubMed ID: 2671163 [TBL] [Abstract][Full Text] [Related]
16. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads. Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147 [TBL] [Abstract][Full Text] [Related]
17. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging. Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023 [TBL] [Abstract][Full Text] [Related]
18. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads. Vredenburgh JJ; Simpson W; Memoli VA; Ball ED Cancer Res; 1991 May; 51(9):2451-5. PubMed ID: 1673088 [TBL] [Abstract][Full Text] [Related]
19. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286 [TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation. Kies MS; Gordon LI; Rosen ST; Kucuk O; Vriesendorp HM Exp Hematol; 1988 Mar; 16(3):190-4. PubMed ID: 3276545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]